- Filed
- Feb 26, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2023 · Aug 3, 2023 | 317.73M sh |
| Shares Diluted | Q2 2023 · Jun 30, 2023 | 317.34M sh |
| Shares Diluted | Q2 2023 · Jun 30, 2023 | 316.9M sh |
| Shares Diluted | Q2 2023 · Jun 30, 2022 | 310.58M sh |
| Shares Diluted | Q2 2023 · Jun 30, 2022 | 308.39M sh |
| Capex | Q2 2023 · Jun 30, 2023 | $3.68M |
| Capex | Q2 2023 · Jun 30, 2022 | $12.46M |
| Operating Cash Flow restated | Q2 2023 · Jun 30, 2023 | $30.24M |
| Operating Cash Flow | Q2 2023 · Jun 30, 2022 | $21.48M |
| Long Term Debt | Q2 2023 · Jun 30, 2023 | $289.38M |
| Long Term Debt | Q2 2023 · Dec 31, 2022 | $391.86M |
| Short Term Debt | Q2 2023 · Jun 30, 2023 | $7.15M |
| Short Term Debt | Q2 2023 · Dec 31, 2022 | $7.15M |
| Cash And Equivalents | Q2 2023 · Jun 30, 2023 | $88.15M |
| Cash And Equivalents | Q2 2023 · Dec 31, 2022 | $194.29M |
| Cash And Equivalents | Q2 2023 · Jun 30, 2022 | $274.53M |
| Stockholders Equity | Q2 2023 · Jun 30, 2023 | $793.73M |
| Stockholders Equity | Q2 2023 · Mar 31, 2023 | $787.86M |
| Stockholders Equity | Q2 2023 · Dec 31, 2022 | $778.22M |
| Stockholders Equity restated | Q2 2023 · Jun 30, 2022 | $735.83M |
| Stockholders Equity restated | Q2 2023 · Mar 31, 2022 | $724.35M |
| Stockholders Equity restated | Q2 2023 · Dec 31, 2021 | $701.96M |
| Current Liabilities | Q2 2023 · Jun 30, 2023 | $137.63M |
| Current Liabilities | Q2 2023 · Dec 31, 2022 | $179.57M |
| Total Liabilities | Q2 2023 · Jun 30, 2023 | $533.5M |
| Total Liabilities | Q2 2023 · Dec 31, 2022 | $683.63M |
| Current Assets | Q2 2023 · Jun 30, 2023 | $414.71M |
| Current Assets | Q2 2023 · Dec 31, 2022 | $556.69M |
| Total Assets | Q2 2023 · Jun 30, 2023 | $1.33B |
| Total Assets | Q2 2023 · Dec 31, 2022 | $1.46B |
| Eps Diluted | Q2 2023 · Jun 30, 2023 | −$0.04 |
| Eps Diluted | Q2 2023 · Jun 30, 2023 | −$0.06 |
| Eps Diluted restated | Q2 2023 · Jun 30, 2022 | −$0.13 |
| Eps Diluted restated | Q2 2023 · Jun 30, 2022 | −$0.27 |
| Eps Basic | Q2 2023 · Jun 30, 2023 | −$0.04 |
| Eps Basic | Q2 2023 · Jun 30, 2023 | −$0.06 |
| Eps Basic restated | Q2 2023 · Jun 30, 2022 | −$0.13 |
| Eps Basic restated | Q2 2023 · Jun 30, 2022 | −$0.27 |
| Sga Expense | Q2 2023 · Jun 30, 2023 | $86.63M |
| Sga Expense | Q2 2023 · Jun 30, 2023 | $172.97M |
| Sga Expense restated | Q2 2023 · Jun 30, 2022 | $99.35M |
| Sga Expense restated | Q2 2023 · Jun 30, 2022 | $204.12M |
| Net Income | Q2 2023 · Jun 30, 2023 | −$12.27M |
| Net Income | Q2 2023 · Jun 30, 2023 | −$20.38M |
| Net Income | Q2 2023 · Mar 31, 2023 | −$8.11M |
| Net Income restated | Q2 2023 · Jun 30, 2022 | −$39.31M |
| Net Income restated | Q2 2023 · Jun 30, 2022 | −$82.89M |
| Net Income restated | Q2 2023 · Mar 31, 2022 | −$43.59M |
| Operating Income | Q2 2023 · Jun 30, 2023 | −$1.62M |
| Operating Income | Q2 2023 · Jun 30, 2023 | $4.03M |
| Operating Income restated | Q2 2023 · Jun 30, 2022 | −$21.92M |
| Operating Income restated | Q2 2023 · Jun 30, 2022 | −$61.36M |
| Cost Of Revenue | Q2 2023 · Jun 30, 2023 | $196.34M |
| Cost Of Revenue | Q2 2023 · Jun 30, 2023 | $405.86M |
| Cost Of Revenue restated | Q2 2023 · Jun 30, 2022 | $250.46M |
| Cost Of Revenue restated | Q2 2023 · Jun 30, 2022 | $500.23M |
| Revenue | Q2 2023 · Jun 30, 2023 | $287.22M |
| Revenue | Q2 2023 · Jun 30, 2023 | $594.27M |
| Revenue | Q2 2023 · Jun 30, 2022 | $332.11M |
| Revenue | Q2 2023 · Jun 30, 2022 | $653.05M |